JP2025517341A5 - - Google Patents

Info

Publication number
JP2025517341A5
JP2025517341A5 JP2024568205A JP2024568205A JP2025517341A5 JP 2025517341 A5 JP2025517341 A5 JP 2025517341A5 JP 2024568205 A JP2024568205 A JP 2024568205A JP 2024568205 A JP2024568205 A JP 2024568205A JP 2025517341 A5 JP2025517341 A5 JP 2025517341A5
Authority
JP
Japan
Prior art keywords
formula
sirna molecule
represented
ribonucleoside
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024568205A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517341A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/067039 external-priority patent/WO2023225495A2/en
Publication of JP2025517341A publication Critical patent/JP2025517341A/ja
Publication of JP2025517341A5 publication Critical patent/JP2025517341A5/ja
Pending legal-status Critical Current

Links

JP2024568205A 2022-05-16 2023-05-16 マイクロサテライトdna伸長疾患を治療するための組成物及び方法 Pending JP2025517341A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263342552P 2022-05-16 2022-05-16
US63/342,552 2022-05-16
PCT/US2023/067039 WO2023225495A2 (en) 2022-05-16 2023-05-16 Compositions and methods for treatment of microsatellite dna expansion disorders

Publications (2)

Publication Number Publication Date
JP2025517341A JP2025517341A (ja) 2025-06-05
JP2025517341A5 true JP2025517341A5 (cg-RX-API-DMAC7.html) 2026-05-22

Family

ID=88836271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024568205A Pending JP2025517341A (ja) 2022-05-16 2023-05-16 マイクロサテライトdna伸長疾患を治療するための組成物及び方法

Country Status (7)

Country Link
US (1) US20250346897A1 (cg-RX-API-DMAC7.html)
EP (1) EP4525887A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025517341A (cg-RX-API-DMAC7.html)
CN (1) CN119866220A (cg-RX-API-DMAC7.html)
AU (1) AU2023272008A1 (cg-RX-API-DMAC7.html)
CA (1) CA3257128A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023225495A2 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216556A2 (en) * 2020-04-20 2021-10-28 University Of Massachusetts Oligonucleotides for msh3 modulation

Similar Documents

Publication Publication Date Title
KR102737464B1 (ko) 안지오포이에틴-유사 3 (ANGPTL3)의 발현을 억제하기 위한 RNAi 작용제 및 조성물, 및 사용 방법
US11920132B2 (en) Oligonucleotide therapy for Leber congenital amaurosis
US10538763B2 (en) Compounds and methods for modulation of DUX4
JP2025134688A (ja) α-1アンチトリプシン(AAT)RNAi剤、AAT RNAi剤を含む組成物、及び使用方法。
JP2021533804A5 (cg-RX-API-DMAC7.html)
CN110832077B (zh) 用于抑制α-ENaC表达的RNAi剂及使用方法
JP2024511473A5 (cg-RX-API-DMAC7.html)
JP6771387B2 (ja) 遺伝子サイレンシング用トランスサイレチン対立遺伝子選択的unaオリゴマー
JP2021515784A5 (cg-RX-API-DMAC7.html)
JP2024542738A5 (cg-RX-API-DMAC7.html)
JP2024512635A5 (cg-RX-API-DMAC7.html)
JP2024543952A5 (cg-RX-API-DMAC7.html)
WO2020038973A1 (en) Antisense oligonucleotides targeting sptlc1
JP2025532886A (ja) 神経疾患の処置のための組成物及び方法
JP2025531483A (ja) 神経炎症疾患の治療のための組成物及び方法
EP4426839A1 (en) Lipid conjugation for targeting astrocytes of the central nervous system
JP2007104971A (ja) ミオスタチンのスプライシング制御アンチセンスオリゴヌクレオチド
JP2024518564A (ja) 中枢神経系のニューロンを標的とするための脂質コンジュゲーション
WO2023081822A1 (en) Lipid conjugation for targeting oligodendrocytes of the central nervous system
JP2024542728A5 (cg-RX-API-DMAC7.html)
WO2020038971A1 (en) Antisense oligonucleotides targeting vcan
US20260132400A1 (en) Stabilized rna agents
RU2025110470A (ru) КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ БЕЛКА ТАУ, АССОЦИИРОВАННОГО С МИКРОТРУБОЧКАМИ
RU2025110478A (ru) КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ АЛЬФА-СИНУКЛЕИНА
HK40111119A (en) Oligonucleotide gba agonists